Here are a few highlights of cancer research news that have recently caught my attention:

• A recent study published in JAMA looked at the mutation-specific cancer risks for carriers of BRAC1 and BRAC2. Study conducted by researchers at Bassa Center for BRCA, the Abramson Center and the Perelman School of Medicine at U Penn evaluated 19,581 carriers of BRCA1 mutations and 11,900 carriers of BRCA2 mutations. They concluded that cancer risks varied by type and location of these mutations.

• The New York Daily News recently published a piece authored by Dr. Harold Varmus, former director of the National Cancer Institute, where he talks about the progress in cancer research and what lies ahead.

• According to a study by the American College of Surgeons, socioeconomic factors affect chances of death post lung resection. Study looked at 215, 645 patients.

• Scientists discover new biomarker for uterine cancer. Their hope is that ASRGL1 can become a diagnostic tool to identify women at a higher risk of recurrence. Study is published in Gynecologic Oncology.

• The American Thyroid Association has published its first guidelines ever on managing thyroid nodules and cancer in the pediatric population. The guidelines are freely available on the Thyroid website.

Please feel free to contact Marisol Hernandez to share any comments.